Form 4 for CUE Cue Biopharma, Inc.
Accepted 2021-10-05 00:00:00 ET · period of report 2021-08-23 · accession 0001209191-21-059698 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-10-05 | 2021-08-23+ | CUE | Millar Kerri-Ann | CFO | M - OptEx | $1.18 | +7,918 | 11.7K | +208% | +$9,382 |
| D | 2021-10-05 | 2021-08-23 | CUE | Millar Kerri-Ann | CFO | F - Tax | $0.00 | -1,961 | 10.5K | -16% | $0 |
| D | 2021-10-05 | 2021-10-01 | CUE | Millar Kerri-Ann | CFO | S - Sale+OE | $14.21 | -1,251 | 10.5K | -11% | -$17.8K |
| DM | 2021-10-05 | 2021-08-23+ | CUE | Millar Kerri-Ann | CFO | M - OptEx | $0.00 | -7,918 | 53.7K | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-23 | M | A | 6,667 | $0.00 | 12,433 | D | — | — | (F1) Represents shares of common stock received upon vesting of a restricted stock unit award. |
| 2 | Common | Common Stock | 2021-10-01 | M | A | 1,251 | $7.50 | 11,723 | D | — | — | |
| 3 | Common | Common Stock | 2021-08-23 | F | D | 1,961 | $0.00 | 10,472 | D | — | — | |
| 4 | Common | Common Stock | 2021-10-01 | S | D | 1,251 | $14.21 | 10,472 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.01 to $14.46, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (3) to this Form 4. |
| 5 | Derivative | Restricted Stock Units | 2021-08-23 | M | D | 6,667 | $0.00 | 6,667 | D | — · — to — | 6,667 Common Stock | (F4) Each restricted stock unit award represents a contingent right to receive one share of common stock. (F5) Represents a restricted stock unit award granted on August 21, 2020. The restricted stock units vest in three equal annual installments beginning on August 21, 2020. |
| 6 | Derivative | Stock Option (right to buy) | 2021-10-01 | M | D | 1,251 | $0.00 | 53,749 | D | $7.50 · — to 2024-12-27 | 1,251 Common Stock | (F6) The option vests in eight equal semi-annual installments beginning March 25, 2018. |